Skip to main content
. 2015 Aug 28;13:259. doi: 10.1186/s12957-015-0673-8

Table 2.

Relationship of Hoxd10 expression with pathological parameters of tumor

Clinical parameters HOXD10
Low High t/χ 2 P
Age (years) 59.77 ± 12.44 58.48 ± 11.85 1.107 0.269
Gender 0.519 0.4771
 Male 135 (43.4 %) 176 (56.6 %)
 Female 59 (47.2 %) 66 (52.8 %)
Location 4.379 0.112
 Proximal 31 (56.4 %) 24 (43.6 %)
 Middle 74 (45.4 %) 89 (54.6 %)
 Distal 89 (40.8 %) 129 (59.2 %)
Size 25.716 0.0001
 <5 cm 88 (34.4 %) 168 (65.6 %)
 ≥5 cm 106 (58.9 %) 74 (41.1 %)
Lauren classification 63.165 0.0001
 Intestinal 58 (26.0 %) 165 (74.0 %)
 Diffuse 136 (63.8 %) 77 (36.2 %)
Histology classification 7.343 0.062
 Papillary adenocarcinoma 3 (18.8 %) 13 (81.2 %)
 Tubular adenocarcinoma 142 (43.6 %) 184 (56.4 %)
 Mucinous adenocarcinoma 17 (58.6 %) 12 (41.4 %)
 Signet-ring cell carcinoma 32 (49.2 %) 33 (50.8 %)
Histologic differentiation 5.25 0.154
 Well 3 (23.1 %) 10 (76.9 %)
 Moderately 50 (39.1 %) 78 (60.9 %)
 Poorly 140 (47.8 %) 153 (52.2 %)
 Others 1 (50.0 %) 1 (50.0 %)
Invasion depth 33.892 0.0001
 T1 9 (15.8 %) 48 (84.2 %)
 T2 39 (35.8 %) 70 (64.2 %)
 T3 129 (52.9 %) 115 (47.1 %)
 T4 17 (65.4 %) 9 (34.6 %)
TNM stages 60.859 0.0001
 I 17 (18.9 %) 73 (81.1 %)
 II 30 (28.8 %) 74 (71.2 %)
 III 102 (59.0 %) 71 (41.0 %)
 IV 45 (65.2 %) 24 (34.8 %)
Lymphatic metastasis 45.165 0.0001
 No 40 (24.1 %) 126 (75.9 %)
 Yes 154 (57.0 %) 116 (43.0 %)
Regional lymph nodes 51.95 0.0001
 PN0 40 (24.1 %) 126 (75.9 %)
 PN1 67 (49.3 %) 69 (50.7 %)
 PN2 65 (65.7 %) 34 (34.3 %)
 PN3 22 (62.9 %) 13 (37.1 %)
Distant metastasis 14.821 0.0001
 No 153 (40.8 %) 222 (59.2 %)
 Yes 41 (67.2 %) 20 (32.8 %)